BB BIOTECH NAM. SF 0,20/ CH0038389992 /
| 2025-05-14 8:52:11 PM | Chg. +0.0500 | Volume | Bid8:52:11 PM | Ask8:52:11 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 30.2500EUR | +0.17% | 3,070 Turnover: 93,028.3000 |
-Bid Size: - | -Ask Size: - | 1.67 bill.EUR | - | - |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 1.38 CHF | - |
| EPS Diluted: | - CHF | - |
| Revenues per Share: | - CHF | - |
| Book Value per Share: | 41.27 CHF | -1.59% |
| Cash Flow per Share: | 5.50 CHF | 39.53% |
| Dividend per Share: | 1.80 CHF | -10.00% |
| Total | in mill. | |
| Revenues: | - CHF | - |
| Net Income: | 75.90 CHF | - |
| Operating Cash Flow: | 304.56 CHF | - |
| Cash and Cash Equivalents: | 0.46 CHF | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 20.51 | 25.65 |
| P/S Ratio: | - | - |
| P/BV ratio: | 0.69 | 0.86 |
| P/CF Ratio: | 5.15 | 6.44 |
| PEG: | - | - |
| Earnings Yield: | 4.88% | 3.90% |
| Dividend Yield: | 6.36% | 5.08% |
| Market Capitalization | ||
| Market Capitalization: | 1.67 bill. EUR | 2.09 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 19.37 mill. EUR | 24.27 mill. EUR |
| Shares Outstanding: | 55.4 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 0.00% |
| Net Profit Margin: | 67.62% |
| Return on Equity: | 3.32% |
| Return on Assets: | 3.15% |
Financial Strength
| Liquidity I / Cash Ratio: | - |
| Liquidity II / Quick Ratio: | - |
| Liquidity III / Current Ratio: | - |
| Debt / Equity Ratio: | 5.30% |
| Dynam. Debt / Equity Ratio: | 39.76% |
Efficiency
| Employees: | 86 |
| Personal Expenses / Employee: | - CHF |
| Revenues / Employee: | - CHF |
| Net Income / Employee: | 882,546.51 CHF |
| Total Assets / Employee: | 27,993,011.63 CHF |
| * Fiscal Year End: | 2024-12-31 |
| Accounting Standard: | IFRS |
| Currency: | CHF |
